Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways.
作者:
关键词
(?)-epigallocatechin-3-gallate (PubChem CID: 65064)20(S)-Rh2 (PubChem CID: 119307)ACY-1215 (PubChem CID: 53340666)ACY-241 (PubChem CID: 53340426)Cancer hallmarksCancer therapyFK228 (PubChem CID: 5352062)HDAC6HDAC6 inhibitorsLBH-589 (PubChem CID: 6918837)Natural compoundsPXD101 (PubChem CID: 6918638)SAHA (PubChem CID: 5311)aceroside VIII (PubChem CID: 21637600)butyrate (PubChem CID: 264)curcumin (PubChem CID: 969516)ellagic acid (PubChem CID: 5281855)genistein (PubChem CID: 5280961)salirepol (PubChem CID: 188287)sulforaphane (PubChem CID: 5350)trichostatin A (PubChem CID: 444732)tubacin (PubChem CID: 6675804)tubastatin A (PubChem CID: 49850262)ursodeoxycholic acid (PubChem CID: 31401)ursolic acid (PubChem CID: 64945)
DOI
10.1016/j.phrs.2017.11.004
PMID
29133216
发布时间
2019-01-22
- 浏览5
Pharmacological research
337-356页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文